Learn what Applied Clinical Trial's readers told us in our annual reader's survey.
What Do You Want to Know? A Reader's Survey Tells AllDid you respond to Applied Clinical Trials' reader survey this year? Well, the results are in and those of you who did respond gave us an inside look into what clinical trials professionals are planning for their businesses in the next year and what they want to learn more about both in print and online.
New strategies that respondent's organizations would be undertaking in the next year to remain competitive included increasing efficiencies with technology (70%) and forming partnerships (58%). The hot topics that people want addressed in the next year are good clinical practice (64%), economic impact on the industry (43%), and eClinical (43%).Delving deeper into article topics, respondents want to see more on regulations, Phase II-III trials, education and training, Phase IV trials/postmarketing, and biotechnology.Check out page 8 to see the lucky respondent who won a flat screen television for participating in Applied Clinical Trials' survey this year.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.